Abstract
Purines are extracellular nucleotides that have long-term effects on keratinocyte proliferation, differentiation and death through P2Y1, P2Y2, P2X5 and P2X7 receptors. This study examined changes in expression of these P2 receptors on lower leg epidermal keratinocytes in control and chronic venous insufficiency (CVI) states. Lower limb skin biopsies from CVI (CEAP classification 4a and 4b) and control skin were immunostained for the above P2 receptor subtypes and epidermal area was calculated. Our results with CVI show an increase in P2Y1 and P2Y2 receptor expression in basal and spinosal layers of the epidermis and an increase of P2X5 receptors mainly in the spinosal layer and extending further into the stratum granulosum. In contrast, P2X7 receptors were reduced in the stratum corneum in CVI. In conclusion, a thinner epidermis was found in CVI, which might be the result of the changes in expression of P2Y and P2X receptors on keratinocytes: that is, increased proliferation via P2Y1 and P2Y2 receptors and reduced P2X7 receptor-mediated cell death opposed by a dominant decrease in cell numbers as a result of increased P2X5 receptor-mediated differentiation (which is in effect antiproliferative). Thus, increased keratinocyte P2X5 receptor activity may, in part, be accountable for epidermal thinning in CVI.
Similar content being viewed by others
References
Allegra C, Antignani PL, Bergan JJ, Carpentier PH, Coleridge-Smith P, Cornu-Thenard A, Eklof B, Partsch H, Rabe E, Uhl JF, Widmer MT (2003) The “C” of CEAP: suggested definitions and refinements: an International Union of Phlebology conference of experts. J Vasc Surg 37:129–131
Baricordi OR, Ferrari D, Melchiorri L, Chiozzi P, Hanau S, Chiari E, Rubini M, Di Virgilio F (1996) An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87:682–690
Brough D, Le Feuvre RA, Wheeler RD, Solovyova N, Hilfiker S, Rothwell NJ, Verkhratsky A (2003) Ca2+ stores and Ca2+ entry differentially contribute to the release of IL-1β and IL-1α from murine macrophages. J Immunol 170:3029–3036
Burnstock G (2001) Overview of P2 receptors: possible functions in immune cells. Drug Dev Res 53:53–59
Burnstock G (2002) Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22:364–373
Burnstock G (2004) Adenosine triphosphate (ATP) as a neurotransmitter and neuromodulator. In: Adelman G, Smith BH (eds) Encyclopedia of neuroscience. Elsevier, Amsterdam
Burnstock G, Knight GE (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240:31–304
Coleridge Smith PD (2002) Deleterious effects of white cells in the course of skin damage in CVI. Int Angiol 21:26–32
Di Virgilio F (1995) The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today 16:524–528
Di Virgilio F, Falzoni S, Mutini C, Sanz JM, Chiozzi P (1998) Purinergic P2X7 receptor: a pivotal role in inflammation and immunomodulation. Drug Dev Res 45:207–213
Dixon CJ, Bowler WB, Littlewood-Evans A, Dillon JP, Bilbe G, Sharpe GR, Gallagher JA (1999) Regulation of epidermal homeostasis through P2Y2 receptors. Br J Pharmacol 127:1680–1686
Ferrari D, Villalba M, Chiozzi P, Falzoni F, Ricciardi-Castagnoli P, Di Virgilio F (1996) Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J Immunol 156:1531–1539
Galkowska H, Olszewsk WL, Wojewodzka U, Mijal J, Filipiuk E (2003) Expression of apoptosis- and cell cycle-related proteins in epidermis of venous leg and diabetic foot ulcers. Surgery 134:213–220
Greig AV, Linge C, Terenghi G, McGrouther DA, Burnstock G (2003) Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. J Invest Dermatol 120:1007–1015
Gröschel-Stewart U, Bardini M, Robson T, Burnstock G (1995) Localisation of P2X5 and P2X7 receptors by immunohistochemistry in rat stratified squamous epithelia. Cell Tissue Res 296:599–605
Herrick SE, Sloan P, McGurk M, Freak L, McCollum CN, Ferguson MW (1992) Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 141:1085–1095
Huttunen M, Hyttinen M, Nilsson G, Butterfield JH, Horsmanheimo M, Harvima IT (2001) Inhibition of keratinocyte growth in cell culture and whole skin culture by mast cell mediators. Exp Dermatol 10:184–192
Junger M, Steins A, Hahn M, Hafner HM (2000) Microcirculatory dysfunction in chronic venous insufficiency (CVI). Microcirculation 7:S3–S12
Korthuis RJ, Unthank JL (2000) Experimental models to investigate inflammatory processes in chronic venous insufficiency. Microcirculation 7:S13–S22
Labasi JM, Petrushova N, Donovan C, McCurdy S, Lira P, Payette MM, Brissette W, Wicks JR, Audoly L, Gabel CA (2002) Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168:6436–6445
Lee YH, Lee SJ, Seo MH, Kim CJ, Sim SS (2001) ATP-induced histamine release is in part related to phospholipase A2-mediated arachidonic acid metabolism in rat peritoneal mast cells. Arch Pharm Res 24:552–556
Leu HJ, Wenner A, Spycher MA, Brunner U (1980) Changes in the transendothelial permeability as the origin of edema in chronic venous insufficiency. Med Welt 31:781–785
Namazi MR (2004) Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders. Int Immunopharmacol 4:349–353
Okamoto H, Mizuno K, Horio T (2003) Monocyte-derived multinucleated giant cells and sarcoidosis. J Dermatol Sci 31:119–128
Pascarella L, Schonbein GW, Bergan JJ (2005) Microcirculation and venous ulcers: a review. Ann Vasc Surg 19:921–927
Peschen M, Grenz H, Lahaye T, Brand-Saberi B, Simon JC, Schopf E, Vanscheidt W (1997) Changes of cytokeratin expression in the epidermis with chronic venous insufficiency. VASA 26:76–80
Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413–492
Saharay M, Shields DA, Porter JB, Scurr JH, Coleridge Smith PD (1997) Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg 26:265–273
Saharay M, Shields DA, Georgiannos SN, Porter JB, Scurr JH, Coleridge Smith PD (1998) Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg 15:342–349
Sandor T (2004) Pathomechanism of chronic venous insufficiency and leg ulcer. Acta Physiol Hung 91:131–145
Vanscheidt W, Laaff H, Weiss JM, Schopf E (1991) Immunohistochemical investigation of dermal capillaries in chronic venous insufficiency. Acta Derm Venereol 71:17–19
Weyl A, Vanscheidt W, Weiss JM, Peschen M, Schopf E, Simon J (1996) Expression of the adhesion molecules ICAM-1, VCAM-1, and E-selectin and their ligands VLA-4 and LFA-1 in chronic venous leg ulcers. J Am Acad Dermatol 34:418–423
Zheng LM, Zychlinsky A, Liu CC, Ojcius DM, Young JD (1991) Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 112:279–288
Acknowledgments
We would like to thank the vascular surgeons at the Royal Free Hospital, Pond St, London and the cardiothoracic surgeons at the Heart Hospital, Westmoreland St, London, for their careful excision of the skin biopsies.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Metcalfe, M.J., Baker, D.M. & Burnstock, G. Purinoceptor expression on keratinocytes reflects their function on the epidermis during chronic venous insufficiency. Arch Dermatol Res 298, 301–307 (2006). https://doi.org/10.1007/s00403-006-0693-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-006-0693-x